Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ADAM S KOTOWSKI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1992813828
CMS profile
181185
Location
WILLIAMSVILLE, NY

General Payments · PY2018–2024

$27,333.09

  • Reported across 172 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,318.18

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,300.00 1
Long term medical supply or device loan $1,080.33 11
Food and Beverage $937.85 40

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,946.22 31
PY2019 $9,531.41 24
PY2020 $3,422.79 13
PY2021 $2,661.02 15
PY2022 $1,986.66 14
PY2023 $466.81 23
PY2024 $4,318.18 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $34.67 05/14/2024 Food and Beverage Undisputed 01/23/2026 1104103234 CMS
ABBVIE INC. $22.21 09/19/2024 Food and Beverage Undisputed 01/23/2026 1104103236 CMS
Alexion Pharmaceuticals, Inc. $22.41 10/11/2024 Food and Beverage Undisputed 01/23/2026 1093946654 CMS
Alnylam Pharmaceuticals Inc. $11.35 04/12/2024 Food and Beverage Undisputed 01/23/2026 1125832565 CMS
Alnylam Pharmaceuticals Inc. $2,300.00 06/13/2024 Consulting Fee Undisputed 01/23/2026 1125832581 CMS
ARRAY BIOPHARMA INC $15.80 10/16/2024 Food and Beverage Undisputed 01/23/2026 1131380252 CMS
AstraZeneca Pharmaceuticals LP $124.99 02/15/2024 Food and Beverage Undisputed 01/23/2026 1105360263 CMS
AstraZeneca Pharmaceuticals LP $19.79 05/10/2024 Food and Beverage Undisputed 01/23/2026 1105850982 CMS
AstraZeneca Pharmaceuticals LP $21.80 08/14/2024 Food and Beverage Undisputed 01/23/2026 1104512946 CMS
AstraZeneca Pharmaceuticals LP $19.01 09/11/2024 Food and Beverage Undisputed 01/23/2026 1104555382 CMS
E.R. Squibb & Sons, L.L.C. $14.82 05/15/2024 Food and Beverage Undisputed 01/23/2026 1101417693 CMS
Genentech USA, Inc. $17.13 03/25/2024 Food and Beverage Undisputed 01/23/2026 1132972113 CMS
Genentech USA, Inc. $18.97 04/22/2024 Food and Beverage Undisputed 01/23/2026 1132972109 CMS
Genentech USA, Inc. $14.12 12/05/2024 Food and Beverage Undisputed 01/23/2026 1132972111 CMS
GENZYME CORPORATION $28.08 05/08/2024 Food and Beverage Undisputed 01/23/2026 1139789209 CMS
GENZYME CORPORATION $13.08 09/25/2024 Food and Beverage Undisputed 01/23/2026 1139789237 CMS
GENZYME CORPORATION $22.83 10/31/2024 Food and Beverage Undisputed 01/23/2026 1139789257 CMS
GlaxoSmithKline, LLC. $18.95 12/04/2024 Food and Beverage Undisputed 01/23/2026 1116301032 CMS
HEMA Biologics, LLC $32.08 05/08/2024 Food and Beverage Undisputed 01/23/2026 1152820985 CMS
Janssen Biotech, Inc. $25.76 02/09/2024 Food and Beverage Undisputed 01/23/2026 1078484565 CMS
Janssen Biotech, Inc. $29.08 05/09/2024 Food and Beverage Undisputed 01/23/2026 1078483827 CMS
Janssen Biotech, Inc. $36.17 06/15/2024 Food and Beverage Undisputed 01/23/2026 1078481503 CMS
Janssen Biotech, Inc. $30.28 09/20/2024 Food and Beverage Undisputed 01/23/2026 1078483563 CMS
Janssen Biotech, Inc. $1.94 09/20/2024 Food and Beverage Undisputed 01/23/2026 1078484731 CMS
Janssen Biotech, Inc. $24.52 10/11/2024 Food and Beverage Undisputed 01/23/2026 1078484502 CMS
Merck Sharp & Dohme LLC $23.53 05/24/2024 Food and Beverage Undisputed 01/23/2026 1141884399 CMS
Merck Sharp & Dohme LLC $23.37 10/23/2024 Food and Beverage Undisputed 01/23/2026 1141745421 CMS
Merck Sharp & Dohme LLC $25.76 12/16/2024 Food and Beverage Undisputed 01/23/2026 1141745423 CMS
Novartis Pharmaceuticals Corporation $99.70 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030578 CMS
Novartis Pharmaceuticals Corporation $99.70 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030580 CMS
Novartis Pharmaceuticals Corporation $10.37 03/07/2024 Food and Beverage Undisputed 01/23/2026 1087030564 CMS
Novartis Pharmaceuticals Corporation $99.70 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030582 CMS
Novartis Pharmaceuticals Corporation $19.22 04/11/2024 Food and Beverage Undisputed 01/23/2026 1087030566 CMS
Novartis Pharmaceuticals Corporation $99.70 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030584 CMS
Novartis Pharmaceuticals Corporation $99.70 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030586 CMS
Novartis Pharmaceuticals Corporation $7.23 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087030568 CMS
Novartis Pharmaceuticals Corporation $99.70 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030598 CMS
Novartis Pharmaceuticals Corporation $12.69 06/20/2024 Food and Beverage Undisputed 01/23/2026 1087030570 CMS
Novartis Pharmaceuticals Corporation $99.70 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030600 CMS
Novartis Pharmaceuticals Corporation $8.73 07/17/2024 Food and Beverage Undisputed 01/23/2026 1087030574 CMS
Novartis Pharmaceuticals Corporation $99.70 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030594 CMS
Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030596 CMS
Novartis Pharmaceuticals Corporation $23.81 10/03/2024 Food and Beverage Undisputed 01/23/2026 1087030588 CMS
Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030604 CMS
Novartis Pharmaceuticals Corporation $26.57 10/31/2024 Food and Beverage Undisputed 01/23/2026 1087030590 CMS
Novartis Pharmaceuticals Corporation $83.33 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087030602 CMS
Novo Nordisk Inc $22.87 05/01/2024 Food and Beverage Undisputed 01/23/2026 1096693375 CMS
PFIZER INC. $22.80 08/05/2024 Food and Beverage Undisputed 01/23/2026 1131887031 CMS
PFIZER INC. $16.59 10/24/2024 Food and Beverage Undisputed 01/23/2026 1131375456 CMS
SOBI, INC $20.52 11/04/2024 Food and Beverage Undisputed 01/23/2026 1141412260 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.03 06/03/2024 Food and Beverage Undisputed 01/23/2026 1144961052 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.92 09/18/2024 Food and Beverage Undisputed 01/23/2026 1144961054 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.